pancreatic cancertype 2 diabetes mellitusT2DMrecurrent acute pancreatitischronic pancreatitisGLP-1 receptor agonistTriNetX Collaborative NetworkGLP-1 receptor agonists
… [5.2%] vs 335/3,410 [9.8%]; HR 0.551, 95% CI 0.461-0.659), and pancreatic cancer (132/6,253 [2.1%] vs 273/6,069 [4.5%]; HR 0.481, 95% CI 0.390-0…